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Introduction
Initial assessment of a woman with a breast lump is clinical.
Women with significant breast symptoms or signs should be
referred to a designated breast clinic where a diagnostic pro-
cess is carried out, initially by a surgeon with a specific interest
and training in breast disease.1 With regard to the specific
complaint of a lump, the family physician should refer the
woman for such assessment once this is confirmed on physical
examination (i.e. the presence of a true discrete palpable
abnormality).2 While clinical examination generally plays a
much more important role than history in the diagnostic
assessment,3 the latter tells us of the likelihood of a diagnosis
and identifies women at risk of future breast cancer. This will
be elaborated on in this article, which discusses the approach
to a woman with a breast lump from the Asia Pacific regional
perspective. The management of women with the same prob-
lem from different geographical regions may differ depending
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on the availability of specialist personnel and facilities, as well
as variation in disease patterns. The latter may reflect not only
the preponderance of certain diseases, but also the socioeco-
nomic/educational status and cultural/religious beliefs that
affect their presentation (e.g. stages of cancer). Throughout
the article, the discussion refers to this regional perspective.
Clinical assessment
Clinical assessment comprises history taking and physical
examination. The technique of physical examination has been
previously described and will not be repeated here.3 While the
aim of clinical assessment is primarily diagnostic (i.e. arriving
at the clinical diagnosis of the lump), history taking also
assists in identifying women at risk of developing breast can-
cer so that appropriate action may be taken. In this section, the
differential diagnoses for a woman with a breast lump are
presented, followed by a brief discussion of the significance of
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a history of breast diseases and family history of breast cancer
(Table).
Differential diagnoses
The four main differential diagnoses are malignancy, in-
flammation, solid non-inflammatory lumps and cysts. As-
sociated symptoms such as nipple discharge and mastalgia
may be present and require assessment as appropriate. The
assessment approach has been previously described and will
not be discussed here.2
Malignancy
Although the causes remain uncertain, it is well known that
the incidence of breast cancer varies from one region to another.
Breast cancer is more common in North America, Europe
and Australia with an age-standardized incidence of up to
90/100,000, while the age-standardized incidence in East Asia
is below 20/100,000 (Figure 1).4 Breast cancer incidence in-
creases with age, but the life-time risk of the disease varies from
region to region. For example, it is 1:9 in the USA, 1:12 in the
UK and 1:20–30 in Asia Pacific countries such as Hong Kong
and Singapore. There are also data suggesting differences in
incidence among women of different ethnic origins within the
same country. For example, in South Africa, the risk of breast
cancer is 1:81 for black women and 1:13 for white women.4
While genetic mutations account for approximately 10% of all
breast cancers, it is likely that these differences may reflect
different lifestyles among these populations. These data re-
flect the likelihood of developing cancer in women who present
with a breast lump in different and/or similar geographical
regions.
The stage of cancer at presentation also varies according to
region. This is most related to the degree of breast awareness,
which is in turn influenced by education, socioeconomic status,
cultural/religious beliefs and access to medical facilities. Us-
Table. Differential diagnoses of a breast lump
Diagnosis Factors influencing likelihood of diagnosis and presentation
Malignancy Geographical area, age, ethnic origin, at-risk groups (significant family history, high-risk
   pathology such as ADH, ALH, LCIS, and others such as previous radiotherapy)
Inflammation Pregnancy and lactation, puerperal care and health education, smoking, geographical
   area, endemic infections
Non-inflammatory solid lumps Age, geographical area, ethnic origin
Cysts Age, hormone replacement therapy
ADH = atypical ductal hyperplasia; ALH = atypical lobular hyperplasia; LCIS = lobular carcinoma in situ.
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Figure 1. Age-standardized incidence and mortality rates of breast
cancer in different countries.
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Figure 2. Stages of breast cancer at presentation in South Africa.
■ Black   ■ Non-black
ing South Africa as an example, although black women have a
lower incidence of breast cancer, only a small number present
with early disease compared with their white counterparts
(22% vs 69% with stage I/II) (Figure 2).4 The same phenomenon
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was described for India, where larger, poorer populations have
less breast cancer but present at a much later stage.4 The
reasons given include mainly cultural and educational factors
and access to health care facilities. Black women (and perhaps
many others) consider cancer a social stigma. In the principal
author’s personal experience in Hong Kong in the late 1990s,
where most women with primary breast cancer present as early
as in Western countries (with a mean histological tumour size
of 2.5 cm),5 women who presented with larger breast lumps
due to cancer were generally elderly or younger women who
were widowed or single, especially those with lower socioeco-
nomic status or psychological/psychiatric disorders. There
has been a trend in Hong Kong towards detection of smaller
tumours: in 1971–1990, only 6% of breast cancers were less
than 2 cm in maximum diameter,6 while at the same centre in
1980–19947 and 1995–1999,5 there was a reduction in mean
tumour size from 3.6 cm to 2.5 cm. This was most probably
due to increasing breast awareness rather than screening,
which was not popular in Hong Kong during those periods.
Malignancies other than carcinoma should also be consid-
ered although they are uncommon. For example, lymphoma
of the breast accounts for less than 1% of all non-Hodgkin’s
lymphoma and approximately 0.1% of all breast malignancies.
Secondary malignancies to the breast are rare.
Inflammation
Inflammatory causes of a breast lump may vary according to
personal habits and disease patterns (e.g. infection) in a par-
ticular region. An inflammatory mass in the breast may or may
not be due to an infective cause (Figure 3). The preponderance
of lactational mastitis and abscesses may be related to the
standard of health education and postnatal care that women
receive. Virtually all cases of periductal mastitis and related
mammillary duct fistula are associated with a chronic smok-
ing history and tend to occur in women in their 30s–50s. The
problem is recurrent and chronic, causing scarring and disfig-
urement of the nipple-areolar complex. Other infective causes
of a breast lump tend to occur in areas other than the central
periductal area (i.e. so-called lobular type). They are generally
due to chronic infections from mycobacteria or parasites,
usually occurring in endemic areas. For example, filariasis is
commonly reported in tropical and subtropical areas includ-
ing India, South and Central America, the middle of Africa,
northern Australia and Southeast Asia.8,9 Breast involvement
often manifests in the chronic stage with the adult worm
undergoing degeneration with necrosis. This elicits granulo-
matous inflammation blocking lymphatics and producing a
palpable abnormality.8 However, filariasis may still present in
non-endemic areas – there are case reports from Hong Kong
and the UK, for instance.10,11 On the other hand, it has been
reported that wide differences in the frequency of tuberculosis
of the breast can be seen within endemic areas, as in a study
comparing its incidence across three non-Western countries
(Hong Kong, India and northern Nigeria) in the 1980s, when
the disease was common.12–14 This once again reiterates the
significance of variation within the same region due to factors
such as socioeconomic/educational status and cultural/reli-
gious beliefs among different communities.
Non-infective inflammatory causes are usually chronic
granulomatous inflammation. They may be non-specific or
specific (e.g. sarcoidosis, foreign body). These specific causes
again vary from one region to another and they also vary
according to the woman’s personal history. For instance, the
injection of liquid paraffin wax was a form of breast augmen-
tation practised in Hong Kong from 1950 to the 1960s. Forty-
three cases of paraffinomas were reported by a local teaching
hospital after a median of 17 years following the initial injec-
tion.15 These presented as irregular hard masses that might be
ulcerated or infected. The differential diagnoses are carcino-
ma and other granulomatous inflammation such as tuber-
culosis.
Solid non-inflammatory lumps
These are mostly due to fibroadenomas. They are commonly
seen in young women in their 20s and 30s. In the principal
author’s series of 136 patients with fibroadenoma excised at a
day surgery unit in Hong Kong, the mean age was 32 years
(range, 14–71 years) [unpublished data]. There appears to be
no notable difference in the presentation of symptomatic
fibroadenomas between Western and non-Western popula-
tions.12–14 However, Alagaratnam et al reported that most
giant fibroadenomas (* 5 cm) seen in Hong Kong occurred in
adolescents and young adults and that the bimodal age distri-
bution (i.e. with another peak in an older age group) describedFigure 3. Inflammatory causes of a breast lump.
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in Caucasians was not seen.16 In India, phyllodes tumour has
been diagnosed with different frequencies in different centres
as well as in different racial groups.13 Nevertheless, it must be
noted that, no matter how the frequency of presentation may
vary from one region to another, the clinical features of the
lesion (e.g. fibroadenoma or phyllodes tumour) remain the
same.
Cysts
Cysts are generally innocent and are now considered an
aberration of normal development and involution (ANDI),
although occasionally intracystic carcinoma may be found.
Symptomatic cysts are found mainly in women in their 30s to
late 40s/early 50s. Cysts are uncommon in postmenopausal
women unless they are receiving hormone replacement therapy
(HRT). The likelihood of encountering a postmenopausal
woman with symptomatic breast cysts hence depends signi-
ficantly on the frequency of HRT use in the population con-
cerned. Data are currently lacking on the number of women
on HRT and the duration of use across different countries,
although it may be expected that the use of HRT is less popular
in undeveloped or developing countries. In a recent cohort of
187 Hong Kong Chinese women who were on HRT, the 5-year
compliance rate (71%) was comparable to that in their Cauca-
sian counterparts.17 However, it must be noted that these
women were from a highly selected group first seen at a
specialist unit. According to the second author, it appears very
different from the general experience at the primary care level.
History of breast diseases
When assessing a woman with a breast lump, it is important to
enquire about her history of breast diseases, especially biopsy
or surgery. The presence of a surgical scar implies some impor-
tant information. Scarring may affect the interpretation of a
clinical (e.g. tether) and/or radiological (e.g. distortion on
mammogram) abnormality that would otherwise most prob-
ably be due to an underlying malignancy. Details of previous
operations may reveal the presence of a high-risk pathology,
such as atypical ductal hyperplasia (ADH), atypical lobular
hyperplasia and lobular carcinoma in situ, which would put the
woman at significantly higher risk of developing breast cancer
in the future even if the presenting breast lump has been
confirmed to be benign and dealt with. The woman concerned
may need to be referred for further assessment and manage-
ment in an at-risk clinic, which is usually within the capacity
of a specialist breast unit. How these at-risk women with
benign pathology need to be followed is an important issue
that is difficult to address within the limited scope of this
present review. In addition, a history of breast surgery may
reflect the quality of previously received service (which may
vary from one region to another). For example, an inadequate-
ly treated benign phyllodes tumour (with involved excision
margins) is highly susceptible to recurrence, and recurrence
may well be the diagnosis for the presenting breast lump.
A history of radiotherapy to the chest wall/mediastinum
(e.g. for lymphoma), especially if given at a very young age, may
predispose to an increased risk of breast cancer at a later age.
Identification of this small but significant group of women is
therefore important as such women generally require further
assessment and follow-up (e.g. with screening mammography).
Family history
Taking the family history of breast cancer (and other related
cancers such as ovarian cancer) is important to identify women
at risk so that they may be referred to an at-risk/family history
clinic. Although the overall incidence of breast cancer differs
significantly between the East and the West, reports from
Asian countries have shown that the prevalence of known
genetic mutations (such as BRCA1) among women with breast
cancer is similar.18,19 BRCA1 mutations were identified in 3.8%
of 130 Chinese women with breast cancer in Hong Kong.18
The prevalence was reportedly higher among younger women
with breast cancer – around 8% in both Hong Kong and
Singapore.18,19
As mentioned earlier, there are huge variations in cultural/
religious beliefs and socioeconomic/educational status among
different populations, across different regions and within the
same region. These factors may impact on the identification of
these at-risk women, as well as the preponderance of genetic
breast cancer. In some cultures, consanguineous marriages are
popular. This practice often continues even after people of the
same ethnic origin have migrated to another country, as re-
ported recently in the mass media regarding some Asian com-
munities residing in the UK. This may perpetuate genetically
related diseases such as cancer. Furthermore, cancer (especially
breast cancer) may be a stigma for some communities or
individuals. This may pose a challenge in obtaining an accu-
rate family history, particularly in communities with large
extended families.
Investigations
The diagnostic assessment for a woman with a breast lump
should ideally be carried out in a combined clinic run jointly by
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a specialist breast surgeon and radiologist.1 This practice has
become increasingly popular in Western countries and is now
recognized as standard in most places. The principal author
audited the results of his personal series of primary breast
cancer treated in Hong Kong in the late 1990s against the
standard laid down in the UK’s national guidelines.5 Quality
standards in surgical expertise and radiology and pathology
services reached the level required but there was still room for
improvement in the diagnostic services. One of the most
important reasons was that such a combined clinic was not
available and this has remained the case in most centres in
Asia. Regional variations exist in the availability of such com-
bined facilities and expertise. These may undermine the qual-
ity of the diagnostic service (e.g. delay in diagnosis, unneces-
sary procedures such as repeat needle tests or open surgical
biopsies, suboptimal treatment planning and associated
anxiety). Differences in the fundamentals of medical insti-
tutes can be a significant problem in many countries. Debates
at higher levels (e.g. in health authorities, among government
health ministers) are necessary to develop acceptable service
delivery models in the respective regions.
Generally, the diagnostic process comprises triple assess-
ment (clinical, radiological and cytological/histological). The
standard radiological investigation for a discrete lump is an
ultrasound scan with or without additional mammography.
These may vary according to the availability and location of
resources (both personnel and facilities), for example, whether
they are on the same site as the breast clinic. (This reiterates the
importance of establishing a combined surgical/radiological
symptomatic new referrals breast clinic).
Ultrasonography and mammography
Ultrasonography is the best radiological tool to assess a clini-
cally benign breast lump and has been shown to have signifi-
cantly better accuracy (97% vs 87%), sensitivity (93% vs 57%)
and negative predictive value (99% vs 92%) than mammogra-
phy in this respect.20 In the Nottingham Breast Institute, the
current policy is to carry out ultrasound examination for all
women with a clinically palpable, discrete, benign-feeling lump,
followed by ultrasound-guided biopsy as appropriate. Mam-
mography is carried out under two circumstances: when the
lump feels clinically indeterminate, suspicious or malignant
and/or when the woman needs a mammogram for screening
purposes (either as part of a population screening programme
or for high-risk cases, e.g. strong family history, high-risk
pathology such as ADH). From a regional perspective, as previ-
ously mentioned, this approach depends largely on the avail-
ability of facilities as well as expertise in the centre concerned.
Needle biopsy
Needle biopsy is now fundamental for accurate breast diagno-
sis and image-guided techniques are superior to free-hand
methods. It is now generally accepted that core biopsy is
superior to fine needle aspiration cytology.21 Accurate diagno-
sis of a definitive benign lump (e.g. fibroadenoma), invasive (vs
in situ) carcinoma and other conditions (e.g. ADH) is possible
with core biopsy, which also allows for other tests (e.g. oestro-
gen receptor and HER2 status for breast cancer; immunohisto-
chemistry studies for distinction of mammary carcinoma from
other lesions such as lymphoma). Vacuum-assisted biopsy,
with the ability to sample a larger amount of breast tissue, may
also be useful under some circumstances to improve diagnos-
tic yield. All these (diagnostic and subsequent laboratory
techniques) again require expertise, the availability of which
may have regional variations.
Treatment
Treatment for a breast lump depends on the diagnosis after
the triple assessment process described previously.2
Discussion of the management of breast cancer is beyond
the scope of this article, although the authors would like to
emphasize the importance of various influencing factors (e.g.
cultural, religious, socioeconomic, educational and availabil-
ity of health care facilities at various levels) from a regional or
even global perspective. This is the view of a panel of interna-
tional experts from various countries at a recent meeting of the
American Society of Clinical Oncology.4 These factors influ-
ence the stage at which the disease presents and, consequently,
the treatment required: mastectomy versus breast conserva-
tion, reconstruction, use of adjuvant therapies (especially ra-
diotherapy and chemotherapy), and the delivery of treatments
on an outpatient (day patient) or inpatient basis.
Most inflammatory breast lesions do not require surgical
intervention, although sometimes laying open a mammillary
duct fistula may be necessary for recurrent periductal mastitis.
When expertise and facilities allow, most breast abscesses can
be managed conservatively with antibiotics and repeated
ultrasound-guided aspirations, rather than open surgical
drainage. Chronic inflammatory causes may have specific
treatments (e.g. anti-tuberculous drugs, steroids). In addition,
health surveillance measures may be necessary to prevent
spread or recurrence in case sources of infection (e.g. parasitic
infestation) can be identified within a community.
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Other benign lumps generally require no surgical treatment.
Symptomatic cystic lumps can be aspirated to dryness under
ultrasound guidance. Solid lumps, if removal is required,
either for definitive diagnosis or upon the request of the
woman, can be excised in day surgery facilities if available and
appropriate (e.g. day surgery may be inappropriate where
support from someone in the family or emergency access to
hospital is not readily available). In the Nottingham Breast
Institute, most cases of wide local excision or therapeutic
marker excision (with or without axillary node sampling) for
breast cancer are currently carried out in the day surgery unit.
Vacuum-assisted biopsy performed under local anaesthesia
with ultrasound guidance (provided that expertise and facili-
ties are available) offers a potential means of complete removal
of benign lumps as an alternative to surgery.22
Summary
Clinical presentation of and investigation and treatment for
women with breast lumps are hugely influenced by geographi-
cal/regional factors. These include disease patterns and their
presentation (affected by socioeconomic/educational status
and cultural/religious beliefs) and the availability of specialist
health care personnel and facilities. The differential diagnoses
of a breast lump include breast cancer, benign solid and cystic
lumps as well as inflammatory conditions. The likelihood of a
diagnosis is influenced more by the first group of factors (e.g.
geographical area, age, ethnic origin, family history of breast
cancer, presence of high-risk pathology, endemic infections,
smoking, pregnancy and lactation history, puerperal care and
health education). Investigations and treatments vary more
according to the second group of factors (i.e. availability of
expertise and facilities such as a combined diagnostic clinic
staffed by a breast surgeon and radiologist where the breast
radiologist carries out image-guided diagnostic and therapeu-
tic procedures).
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